TFCP2L1 and neoplasm: When tumor formation was measured 4 weeks after transplantation, T24 cells expressing wild‐type or T177E TFCP2L1 exhibited a significantly higher tumor growth than control T24 cells, while cells expressing T177A TFCP2L1 or shTFCP2L1 had significantly reduced tumor growth (Fig 7B and C).